Strategy & Funding Themes

The ViiV Healthcare Positive Action strategy 2020- 2030 was launched in December 2019. 

Click here to download our high-level strategy.

The strategy works towards achieving healthy communities in a world free of AIDS and supports ViiV’s mission of leaving no person living with HIV behind.

Positive Action has developed a logic framework which demonstrates how we will achieve our overall strategy.

Information for grantees who have received funding under the previous programmes (PACF, PAGW, PA, PA MSM&T and PA Europe can be found here).

The new Positive Action strategy has three categories of funding. Challenges, Community Strategic Initiatives and Breakthrough.

For any questions relating to the Positive Action strategy 2020 - 2030 or the funding rounds please send an email to

Innovator Grants

Positive Action invites applications to the 2021 Round 1 funding for Innovator Grants focusing on Community Based Harm Reduction Services.

Your application should be specific in describing how the interventions that you wish to implement is going to support people and communities of people who inject drugs to reimagine and innovate service delivery models that enable person-centred, stigma free and community-based harm reduction and HIV care.

Requests for proposals will be open from 15th January 2021 (23:59 GMT) to 12 February 2021 (23:59 GMT). Applications will be reviewed by the Technical Review Committee at their meeting in March 2021.

Community-based organisations will be supported with individual grants of up to £50,000 per year over two years (up to £100,000 over the two-year period). More information can be found here.

Kindly review the Positive Action Guidance notes and FAQs

Momentum Grants

The Positive Action 2020 Round 2 funding for Momentum Grants focusing on the needs of Adolescent Mothers Living with HIV and their Children is now closed.

Final decisions, verification and contracting will happen from November 2020 onwards. These dates are provided as a guide.


AMPLIFY IMPACT enables the accompaniment, collaboration and learning needed to achieve the goals of the ViiV Healthcare Positive Action strategy, “Healthy Communities in a world free of AIDS”. The approach is based on a respect for human rights and is conscious of power and power relations that lie at the heart of our work. Our starting point is to begin from a clear purpose, intent and alignment to strategy.

AMPLIFY IMPACT consists of a series of support options designed to facilitate joined-up impact, ongoing learning and improvement and builds on and replaces earlier, more limited offers of Technical Assistance.

We believe that non-financial assistance should enable partners to be fit-for-purpose and aligned to our strategy and this will require a degree of flexibility and responsiveness within Positive Action.


Accompaniment: Technical assistance is available to support grantees with an additional fixed budget allocation (up to 10% of total grant size) to procure required technical assistance for institutional strengthening areas. This is only available to grantees in Innovator and Momentum grants and is self-managed by the grantee and reported on, in line with clear pre-defined requirements and criteria. This has to be applied for during the grant application process. This is clearly marked in the application form.

  • Grantees will be able to identify consultants
  • Technical assistance is focused on the areas of institutional strengthening (Organisational development, Governance, Systems, etc.)
  • Capacity building is available in some thematic areas directly related to the project scope and procured by the grantee

For information on this support category and to find out if you are eligible to apply please email: using the subject heading: TA Support Application

Skills Connector: Ability to access advice and short-term, long-distance, specialised support from GSK/ViiV Employees.

Skills Connector focuses on providing a package of support from three hours to ten days (per calendar year) to existing Positive Action grantees. The support available focuses on the following broad areas:

  • Business Development and Change Management
  • Communications (media, messaging and publicity)
  • Data Management and Knowledge Transfer (enhancing data value and distribution)
  • Information Technology (IT) (networking and infrastructure)
  • Representation and Influence (public speaking, effective representation)
  • Sales and/or Marketing (promoting services, securing clients, raising money)

Please note that the Skills connector offer is available to all existing Positive Action grantees.

For information on this support category or to apply please complete the application form  here and email it to: using the subject heading:  Skills Connector Application

Collaboration: Focused and tailor-made grant management support from the Positive Action team and through the Positive Action Allies programme.

  • The grant manager/Ally collaborates with the grantee to ensure strong grant management and overall performance
  • Opportunity to connect with other grantees through relevant Linking-and-Learning events and spaces

For information on this support category and to find out if you are eligible to apply please email: using the subject heading: Collaboration Application

Learning: Linking partners and grantees to lessons, expertise and insights from other grantmaking streams and sharing results across the portfolio (e.g. paediatric AIDS, harm reduction, HIV related stigma, etc.)

  • Thematic Linking-and-Learning spaces (online) and events (online/in person) act as points for learning and exchange, and spaces for initiating new strategic relationships and partnerships amongst grantees
  • Using data and learning to inform and shape policy positions and advocacy positions

For information on this support category and to find out if you are eligible to apply please email: using the subject heading: Learning Application


Breakthrough grants focus on strategic partnerships aimed at achieving targeted and strategic impact in order to achieve HIV targets more effectively and efficiently. The two thematic areas for 2020 – 2023 focus on ending paediatric AIDS by 2025 and ending AIDS amongst people who use drugs.    

Breakthrough grants are only available by invitation.

Paediatric Breakthrough Grant

The Paediatric Breakthrough Partnership is a 3-year commitment to end paediatric AIDS in priority locations, by harnessing the unique strengths of Aidsfonds, EGPAF, PATA, UNICEF and Positive Action – with programmatic alignment with ELMA. With focused, collaborative and complimentary action, this Partnership reflects our shared ambition to end paediatric AIDS by 2025.

The Breakthrough partners, working with government and community, aim to locate, link, treat and retain mothers and children at risk or living with HIV.

The purpose of the Breakthrough Partnership is to:

  • End paediatric AIDS in priority locations through supporting the implementation of a high-quality package of sustainable and replicable interventions that is informed by the UNICEF Paediatric Service Delivery Framework
  • Develop and amplify the evidence that a collaborative approach between national stakeholders (government, clinic and community) works and advocate for governments (and other stakeholders) to adopt such an approach
The Partnership design involves:
  • Year 1 (present – June 2021): focus on Mozambique, Uganda and Nigeria 
  • Year 2 (July 2021 – June 2022): continued implementation and expansion in Year 1 countries; review and feasibility assessment for the remaining countries (Cameroon, Kenya, Malawi and Zimbabwe) 
  • Year 3 (July 2022 – June 2023): further implementation, evaluation and recommendations for scaling up and knowledge sharing across all seven countries
Click here to view the paediatric Breakthrough grant infographic.
The Partnership will also undertake an implementation science research project to help us build and grow from our collaborative approach. The research project will look to understand how well partners work together, and if working together yields greater results than if each partner had worked on their own.

Breakthrough Grant to End AIDS Among People Who Use Drugs

Further information regarding the Breakthrough grant to end AIDS among people who use drugs will be announced in 2020.

Breakthrough grants are only available by invitation



Positive Action Challenges seek to find innovative solutions to a particular issue or challenge.

We are pleased to announce the selected award recipients of the most recent Challenge we ran in partnership with IAS and INPUD. This Challenge invited applications that focus specifically on community or peer-led initiatives that aim to provide comprehensive, innovative and accessible harm reduction services at the community level for people who inject drugs.

The following organisations were selected due to meeting some or all of the following criteria:

  • Community or peer-led.
  • Meaningfully engaging and involving the community of people who inject drugs in the design and delivery of their initiative.
  • Promoting non-stigmatising, inclusive and comprehensive care for people who use drugs.
  • Describing how harm reduction services can be integrated into existing community or local public health HIV support services.
  • Being able to demonstrate how the initiative drives increased and sustained access to HIV services and support through addressing current barriers.
  • Demonstrating how the project can be sustained beyond the award.

Seed award recipients to pilot a new idea:

Zambian Equality Forum Limited
Reducing HIV infection and harm reduction among LGBTI and MSM who inject drugs

Key objectives of the project include identifying and addressing key determinants of risk behaviours among LGBTI and MSM who inject drugs, and expanding tailored, evidence-informed and community led behaviour change interventions.

Find out more here

Teens Link Uganda
Stepping up harm reduction services for people who inject drugs in Wakiso (PWID), Uganda

The project aim is to improve 90-90-90 health outcomes for PWID by using combination prevention approaches such as accelerating access to essential harm reduction services, and addressing human rights, social and structural barriers to access.

Find out more here

Recovering Nepal 
Provisioning for gender friendly harm reduction services to women who use drugs

Project objectives include identifying areas of concentration of women who inject drugs and their behavioural patterns through situational assessment and enabling the target group to access harm reduction services.

Find out more here


Grand award recipient to scale a proven project:

Andrey Rylkov Foundation for Health and Social Justice
The provision of harm reduction services to people who inject drugs on the streets of Moscow

Project objectives include the continuation of outreach work on the streets of Moscow providing integrated services on HIV, HCV, overdose prevention, mental health, legal aid and access to health and rights case management.

Find out more here

Hear from Stephen Rea, Head of ViiV Communications and Government Affairs, and our sponsors, IAS and INPUD at AIDS2020: Virtual below:

The Review Panel


Other members of the review panel

Syda Productions/

Syda Productions/

HIV infections among people who inject drugs are rising. People who inject drugs and their sexual partners accounted for around one fifth of all people newly infected with HIV (outside of sub-Saharan Africa) in 2018. In two regions of the world—eastern Europe and central Asia and the Middle East and North Africa—people who inject drugs accounted for more than one third of new infections in 2018. Viral hepatitis and tuberculosis rates among people who use drugs are also high in many parts of the world. These preventable and treatable diseases, combined with overdose deaths, which are also preventable, are claiming hundreds of thousands of lives each year. In many countries across the globe, injecting drug use is not often acknowledged, and a public health response therefore not implemented.

Harm reduction is rooted in a commitment to addressing discrimination and ensuring that nobody is excluded from the health and social services they may need because of their drug use, their race, their gender, their gender identity, their sexual orientation, their choice of work, or their economic status. The meaningful involvement of people who use drugs in designing, implementing and evaluating programmes and policies that serve them is central to harm reduction.

Comprehensive harm reduction services — including needle–syringe programmes, opioid substitution therapy, drug dependence treatment, overdose prevention and testing and treatment for HIV, tuberculosis and hepatitis B and C— reduce the incidence of blood-borne infections, overdose deaths and other harms.

Innovator Grants

Positive Action invites applications to the 2021 Round 1 funding for Innovator Grants focusing on Community Based Harm Reduction Services.

Your application should be specific in describing how the interventions that you want to implement is going to support people and communities of people who inject drugs to reimagine and innovate service delivery models that enable person-centred, stigma free and community-based harm reduction and HIV care.

The call is open to eight countries where there is a significant rise in HIV incidence among people who inject drugs, established needle and syringe programmes and opioid substitution therapy services, as well as strong potential for adoption of innovative community-led service delivery.

Requests for proposals will be open from 15th January 2021 (23:59 GMT) to 12 February 2021 (23:59 GMT). Applications will be reviewed by the Technical Review Committee at their meeting in March 2021.

Innovator grants: Positive Action will award up to £50,000 per year over two years (up to £100,000 over two years). These grants are focussed on funding novel or innovative interventions at the community level. Please note that only new projects will be funded.

Click here to download a more detailed guidance (in English)

Application Process

All applications must be submitted through the Cyber Grants Portal. You will need to register your profile to gain access even if you have been a previous Positive Action Grantee.

Completing Your Application

Use this link: to create your profile and to complete your application.

Please do not email applications to ViiV Healthcare or Positive Action staff members or Positive Action mailboxes. We will only accept applications via the online application system.

If you have any problems accessing the online system please review Appendix 2, the FAQs in the detailed guidance document and/or contact the Positive Action mailbox:

The application window is open until 12 February 2021 23:59 GMT. Applications will be reviewed by a Technical Review committee in March 2021. Final decision and contracting will happen from May 2021 onwards. These dates are provided as a guide.

Community Emergency Response Fund

ViiV Healthcare’s COVID19 Community Emergency Response Fund supported community-based organisations in their work to address the specific challenges that have arisen for people living with HIV or affected by HIV as a result of the COVID-19 pandemic.

Proposals were received in the following thematic areas:

  • Support for ongoing access to critical HIV prevention, care and treatment services (adherence support interventions, psychosocial support, strengthening access to ARVs, strategies for hard to reach populations, etc.)
  • Capacity building to support the transition of service delivery from face to face service delivery to home or digital services etc.
  • Short term payments for critical community staff who are responding to COVID19 challenges (salaries, airtime, data, transport costs etc.)
  • Community monitoring and community feedback mechanisms on impact of COVID19 HIV services and support.

All recommended applicants have now been informed of the outcome. If you have not heard from the Positive Action team you can assume that your application has been unsuccessful.